Analgesic Efficacy of Blocking Nerve to Vastus Lateralis Muscle Versus Lateral Femoral Cutaneous Nerve After Knee Surgeries
Launched by KAFRELSHEIKH UNIVERSITY · Jan 30, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to manage pain after knee surgeries. Specifically, it compares the effectiveness of blocking a nerve that goes to a muscle called the vastus lateralis versus blocking another nerve known as the lateral femoral cutaneous nerve. The goal is to see which method provides better pain relief and helps patients recover more effectively after their surgery.
To be eligible for this study, participants need to be adults aged 18 and older who are having knee surgery under spinal anesthesia. They should also be in good health or have mild to moderate health issues. However, people who are pregnant, have certain medical conditions, or a history of severe allergies to anesthesia will not be able to take part. If you join the study, you can expect to receive either of the two nerve blocks and will be monitored for pain relief and recovery outcomes after your surgery. This research is important as it could help improve pain management strategies for knee surgery patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years.
- • Both sexes.
- • American Society of Anesthesiologists (ASA) physical status from I to III.
- • Underwent knee surgeries under spinal anesthesia.
- Exclusion Criteria:
- • Pregnancy.
- • Coagulopathy.
- • Neuromuscular disorders.
- • Hematological disorders.
- • Mental disorders.
- • History of multiple traumas or anesthesia drug allergies.
- • Local skin infection at the block site.
- • Body mass index (BMI) greater than 40.
- • Opioid analgesics or abusing opioids.
About Kafrelsheikh University
Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kafr Ash Shaykh, Kafrelsheikh, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported